BioSpace News Archive

Intersect ENT, Inc., a global ear, nose and throat medical technology leader dedicated to transforming patient care, announced that the Company has changed the date of its previously scheduled first quarter 2021 financial results announcement and conference call.

Dyadic International, Inc. announced that it will report its financial results for quarter ended March 31, 2021 and host a corporate update conference call on Thursday, May 13, 2021.

Omnicell, Inc., a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced results for its first quarter ended March 31, 2021.

Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced three upcoming presentations at the 24th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), to be held virtually from May 11-14, 2021.

CooperCompanies, announced it will release second quarter 2021 financial results on Thursday, June 3, 2021, at 4:15 PM ET.

Pharvaris, a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema and other bradykinin-B2-receptor-mediated indications, reported financial results for the year ended December 31, 2020, and provided recent business highlights.

The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock April 29, 2021.

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter 2021 update and financial results on Thursday, May 6 at 4:30 p.m. ET.

Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced that the company will release financial results for its fiscal third quarter period ended March 31, 2021 on Thursday, May 13, 2021 before the market opens.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upcoming virtual investor healthcare conferences during the month of May: